Happi 40 Tablet contains Rabeprazole 40 mg, a proton pump inhibitor (PPI) used to reduce gastric acid secretion in the treatment of various acid-related gastrointestinal disorders. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system located on the gastric parietal cell surface, thereby suppressing the final step of acid production. This medication is indicated for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease, including Helicobacter pylori eradication when used in combination therapy. Happi 40 is effective in providing symptomatic relief from heartburn, acid regurgitation, and other related symptoms by promoting mucosal healing and preventing acid-induced damage. The tablet is typically administered orally once daily, preferably before meals, and dosage adjustments may be necessary based on clinical response and patient-specific factors. Rabeprazole is generally well tolerated; however, potential adverse effects include headache, diarrhea, abdominal pain, and nausea. Long-term use should be monitored due to risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Patients should inform healthcare providers of any concurrent medications to avoid drug interactions. Happi 40 Tablet should be used under medical supervision to ensure safe and effective therapy.